Related references
Note: Only part of the references are listed.Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
Emmanuel Bachy et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL
Norbert Schmitz et al.
BLOOD (2021)
Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases
Chunni Chen et al.
DIAGNOSTIC PATHOLOGY (2021)
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents
Manman Deng et al.
MOLECULAR CANCER RESEARCH (2021)
Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma
Dachuan Huang et al.
BLOOD ADVANCES (2020)
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations
Sakura Tomita et al.
CANCERS (2020)
Clinicopathologic Determinants of Survival in Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma (MEITL): Analysis of a Pooled Database
Philip A. Haddad et al.
BLOOD (2020)
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling
Yosaku Watatani et al.
LEUKEMIA (2019)
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma
Jun Ho Yi et al.
ANNALS OF HEMATOLOGY (2019)
STAT5B(N642H) is a driver mutation for T cell neoplasia
Ha Thi Thanh Pham et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma
Francois Lemonnier et al.
BLOOD (2018)
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma
Keisuke Kataoka et al.
BLOOD (2018)
Double-hit chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain
Elise Chapiro et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network
Camille Laurent et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2
Andrea B. Moffitt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The Genetic Basis of Hepatosplenic T-cell Lymphoma
Matthew McKinney et al.
CANCER DISCOVERY (2017)
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
Cristina Lopez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma
M-L Nairismagi et al.
LEUKEMIA (2016)
Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas
A. Nicolae et al.
LEUKEMIA (2016)
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations
Annalisa Roberti et al.
NATURE COMMUNICATIONS (2016)
Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
F. d'Amore et al.
ANNALS OF ONCOLOGY (2015)
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation
Sophia X. Pfister et al.
CANCER CELL (2015)
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
Laurence de Leval et al.
HAEMATOLOGICA (2015)
Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan
Sakura Tomita et al.
MODERN PATHOLOGY (2015)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Kucuk et al.
NATURE COMMUNICATIONS (2015)
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
Laurence de Leval et al.
HAEMATOLOGICA (2015)
Profile of CD103 Expression in T-cell Neoplasms
Elizabeth A. Morgan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Detailed clinicopathological characteristics and possible Lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan
Kanta Kikuma et al.
HUMAN PATHOLOGY (2014)
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT
Esa Jantunen et al.
BLOOD (2013)
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
Hanna L. M. Rajala et al.
BLOOD (2013)
Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution Experience
Martin H. Voss et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype
S-Y Tan et al.
LEUKEMIA (2013)
Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group
Eric Tse et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets
Marion Travert et al.
BLOOD (2012)
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
Francois Lemonnier et al.
BLOOD (2012)
TET2 and DNMT3A Mutations in Human T-Cell Lymphoma
Lucile Couronne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Type II Enteropathy-Associated T-Cell Lymphoma: A Distinct Aggressive Lymphoma With Frequent γδ T-cell Receptor Expression
John K. C. Chan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project
Jan Delabie et al.
BLOOD (2011)
Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan
Morishige Takeshita et al.
HISTOPATHOLOGY (2011)
Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma
Jian Sun et al.
MODERN PATHOLOGY (2011)
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation
Michal Sieniawski et al.
BLOOD (2010)
Enteropathy-associated T-cell lymphoma-a clinicopathologic and array comparative genomic hybridization study
Young Hyeh Ko et al.
HUMAN PATHOLOGY (2010)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: Clinicopathology and molecular study of five Japanese patients
Takashi Akiyama et al.
PATHOLOGY INTERNATIONAL (2008)
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma
Ken H. Young et al.
BLOOD (2007)
Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes
Ronald J. Deleeuw et al.
GASTROENTEROLOGY (2007)
Redefining tumour suppressor genes: exceptions to the two-hit hypothesis
AJW Paige
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas
K Blakolmer et al.
MODERN PATHOLOGY (2000)